@@ -11,6 +13,17 @@ export function HPIntegrated(){
...
@@ -11,6 +13,17 @@ export function HPIntegrated(){
return(
return(
<Sectiontitle="Integrated Human Practices"id="Integrated Human Practices">
<Sectiontitle="Integrated Human Practices"id="Integrated Human Practices">
<Subesctiontitle="Framework"id="Integrated Human Practices1">
<Subesctiontitle="Framework"id="Integrated Human Practices1">
<p>Our team has defined a framework for managing interactions with stakeholders during each step of the project:
</p>
<ol>
<li><b>Stakeholder Management Framework </b>- To identify stakeholders and define how potential stakeholders fit our project.</li>
<li><b>Power-Interest Matrix </b>- According to Mendelow to identify and evaluate the priorities of potential stakeholders.</li>
<li><b>SWOT analysis</b> - Assessment of the strengths, weaknesses, opportunities and threats of the various groups previously identified as potential stakeholders.</li>
<li><b>AREA Framework</b> - To structuring and optimizing project-related decisions.</li>
<li><b>Feedback-Cycle</b> - To structure interactions with stakeholders for efficient and informative design and maximization of potential.</li>
<li><b>Third-Party Feedback Templates </b>- To introduce the stakeholders, summarize the interactions and implement the output in our project.</li>
<li><b>Cycle of Reflection</b> - According to Gibbs demonstrate the response and implementation as a part of our feedback cycle.</li>
<p>To clearly communicate to our stakeholders how they can support the <PreCyse/> project and the specific areas requiring
their input, we developed a stakeholder management framework highlighting four key areas. Starting at the bottom right of the
figure and moving clockwise, the first area needing feedback is <b>implementation</b>. It is crucial for our team to ensure that the project
has all necessary components for realistic application in healthcare settings, focusing on the gene therapy treatment for cystic fibrosis.
This includes both the technical design and the appropriate business model to ensure successful implementation.
</p>
<p>The second key area is <b>sustainability and social impact.</b> We seek to understand how our project aligns with current healthcare initiatives and facilities in Germany and Europe, but also in the global situation and its interaction with social efforts related to CF awareness and gene therapy strategies.
</p>
<p>Next, we want to shape the <b>public perception</b> of our project, which uses synthetic biology to tackle a major healthcare challenge. We ask stakeholders about their knowledge and opinions on our gene therapeutic approach and its potential application to improve CF treatments.
</p>
<p>The final area involves <b>regulatory and safety considerations</b>. Given the stringent regulations governing healthcare in Germany, which vary by municipality, it is essential to consult with stakeholders familiar with these regulations to ensure our project complies with all necessary safety standards.
